Literature DB >> 12027867

Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase.

U Seeland1, C Haeuseler, R Hinrichs, S Rosenkranz, T Pfitzner, K Scharffetter-Kochanek, M Böhm.   

Abstract

BACKGROUND: TGF-beta(1) mediates effects on fibroblast proliferation and collagen synthesis in the myocardium. The extracellular matrix remodeling depends on the fibrillar collagen degrading matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). The in vivo effects of TGF-beta(1) on the MMP/TIMP system in TGF-beta(1) overexpressing transgenic mice were studied.
METHODS: Male Alb/TGF-beta(1)(cys(223,225)ser) transgenic mice (TG) and nontransgenic controls (C; 8 weeks) were examined. Protein expression of collagen type I, -III, interstitial collagenase (Int Coll), MMP-2, -9, TIMP-1, -2, -4 and TGF-beta(1) as well as enzyme activity (MMP-2, -9) were measured (Western blots, zymographic assays). mRNA expression of the interstitial collagenase and MMP-9 was studied with the Light-Cycler based real-time PCR.
RESULTS: Overexpression of TGF-beta(1) resulted in a 10-fold increase in plasma and a seven-fold increase in myocardial TGF-beta(1) concentrations. Relative heart weights increased (mg g(-1): 7.8 +/- 0.4 vs. 4.8 +/- 0.6, n = 6; P < 0.01) in TG compared to C. Collagen type I and III increased in TG (1.9-fold and 1.7-fold) compared to controls. Interstitial collagenase protein activity (- 91%) and mRNA expression (-75%) in TG were reduced (P < 0.05-P < 0.001). Gelatinase (MMP-2, MMP-9) expression and activity were not significantly alterated. MMP-inhibitors were increased 2.5-fold (TIMP-1, -4) and 6-fold (TIMP-2) in TG.
CONCLUSIONS: TGF-beta(1) produces myocardial fibrosis in vivo. This effect is not only produced by a stimulation of matrix protein formation: a complex regulation of MMP and TIMP interaction, namely decrease of expression and activity of interstitial collagenase and an enhanced inhibition by increased levels of TIMPs, are involved. These mechanisms are optional targets for therapeutic interventions in myocardial diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027867     DOI: 10.1046/j.1365-2362.2002.00985.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  39 in total

1.  The role of nitric oxide during healing of trauma to the skeletal muscle.

Authors:  Lidiane Isabel Filippin; María José Cuevas; Elena Lima; Norma Possa Marroni; Javier Gonzalez-Gallego; Ricardo Machado Xavier
Journal:  Inflamm Res       Date:  2010-11-13       Impact factor: 4.575

2.  Mediators leading to fibrosis - how to measure and control them in tissue engineering.

Authors:  Xd Mu; Ih Bellayr; Tj Walters; Y Li
Journal:  Oper Tech Orthop       Date:  2010-06-01

Review 3.  Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium.

Authors:  Francesco S Loffredo; Andriana P Nikolova; James R Pancoast; Richard T Lee
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 4.  Zebrafish heart regeneration: Factors that stimulate cardiomyocyte proliferation.

Authors:  D A Zuppo; M Tsang
Journal:  Semin Cell Dev Biol       Date:  2019-09-25       Impact factor: 7.727

Review 5.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Bharathi Upadhya; George E Taffet; Che Ping Cheng; Dalane W Kitzman
Journal:  J Mol Cell Cardiol       Date:  2015-03-06       Impact factor: 5.000

6.  MicroRNA-663 participates in myocardial fibrosis through interaction with TGF-β1.

Authors:  Xiangyang Wu; Jie Zhu; Yalin Wei; Xinqiang Guan; Yanchun Zhang; Wensheng Chen; Bingren Gao
Journal:  Exp Ther Med       Date:  2019-08-16       Impact factor: 2.447

7.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

8.  Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.

Authors:  Kameshwar P Singh; Herve C Gerard; Alan P Hudson; Dov L Boros
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

Review 9.  Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

Authors:  Deborah A Siwik; Wilson S Colucci
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 10.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.